errors.

To avoid this:

• Establish a PSUR calendar synced with regional requirements
• Send DLP reminders 30-60 days in advance
• Use automated alerts within validated pharmacovigilance systems

3. Discrepancies in Benefit-Risk Assessments

Many PSURs contain inconsistent or generic benefit-risk analyses that do not align with the safety findings or signal evaluation sections. This undermines the credibility of the report and can raise red flags during audits or inspections.

Ensure that:

• All significant safety issues discussed in Section 7 are reflected in Section 8
• Benefit-risk is customized for product use patterns and patient populations
• The impact of labeling or RMP updates is transparently integrated

4. Poor Formatting and Non-Compliance with ICH Structure

Incorrect formatting, missing headers, or inconsistent document structures are among the most frequent PSUR issues flagged during GMP compliance audits. Agencies such as the EMA and USFDA expect strict adherence to the ICH E2C(R2) PBRER format.

Recommendations:

• Use master templates with predefined headers and section numbers
• Conduct peer reviews and formatting audits prior to finalization
• Standardize referencing for tables, annexures, and figures

5. Omissions in Cumulative Data Presentation

Incomplete cumulative tabulations or omission of specific safety events compromise the integrity of PSURs. Errors in sorting, filtering, or merging data from different sources are common contributors.

Prevent this by:

• Maintaining a centralized safety data repository
• Auditing data sources prior to merging
• Performing QA spot-checks on cumulative line listings and tabulations

6. Failure to Integrate Local Regulatory Requirements

While ICH guidelines are global, individual countries like India, Japan, and Brazil have specific PSUR requirements. Submitting a generic PSUR without tailoring it for local regulations may lead to rejections or queries.

To avoid this:

• Maintain a regulatory intelligence matrix by country
• Assign local reviewers for each regional PSUR
• Embed jurisdiction-specific requirements into your Pharma SOPs

7. Lack of Quality Review and Approval Workflow

Often, PSURs are prepared under time pressure and bypass adequate internal review, leading to factual or typographical errors. This is particularly problematic when multiple regions and languages are involved.

Establish:

• Multi-level internal QA review and sign-off
• Version-controlled document tracking
• Documented CAPAs for audit findings

8. Inadequate Justification for Changes or No Changes

PSURs must include explanations for both implemented and non-implemented safety actions. Failure to justify why a signal didn’t lead to a label update or why a previous action was effective is viewed negatively during inspections.

Best practice:

• Include clear rationale for each change or lack thereof
• Use historical PSUR data for trend justification
• Include summary tables of actions since the last DLP

9. Disorganized Annexures and Incomplete Documentation

Missing or mislabeled annexures—like line listings, narratives, or tabulations—can result in rejection or requests for clarification from regulators.

Ensure:

• Every annexure is clearly indexed and referenced
• All required documents are attached in the correct format
• Submit through the appropriate platform (e.g., eCTD)

10. Neglecting Post-Submission Follow-Up

After submission, sponsors must track acknowledgment, queries, and feedback from regulatory authorities. Ignoring or missing post-submission interactions can delay approvals or trigger penalties.

Recommended actions:

• Use a PSUR compliance dashboard to track submission status
• Assign a regulatory affairs liaison for follow-up communications
• Document all agency interactions for inspection readiness

Conclusion

PSUR compilation is a meticulous process that requires coordination, attention to detail, and compliance with evolving global standards. By recognizing and addressing the most common pitfalls—from formatting errors to benefit-risk inconsistencies—organizations can significantly enhance the quality of their PSURs. Leveraging validated systems, compliance-driven workflows, and harmonized SOPs ensures your reports meet regulatory expectations and support patient safety effectively.